Test ID: 2D6T
Cytochrome P450 2D6 Genotype for Tamoxifen Hormonal Therapy
Secondary ID 
A test code used for billing and in test definitions created prior to November 2011
87966
NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.
Conditional
Useful For Suggests clinical disorders or settings where the test may be helpful
Determining the CYP2D6 genotype of patients considered for tamoxifen chemotherapy
Testing Algorithm Delineates situation(s) when tests are added to the initial order. This includes reflex and additional tests.
Special Instructions and Forms Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test
Method Name A short description of the method used to perform the test
Polymerase Chain Reaction (PCR) with Allele-Specific Primer Extension (ASPE)/Bead Hybridization with Fluorescence Detection
(PCR is utilized pursuant to a license agreement with Roche Molecular Systems, Inc.)
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
CYP2D6 Genotype - Tamoxifen Therapy
Aliases Lists additional common names for a test, as an aid in searching
2D6
Breast Cancer Therapy
CYP
CYP2D6
CYP2D6 for Breast Cancer
Cytochrome
P450
Breast Cancer Therapy
CYP
CYP2D6
CYP2D6 for Breast Cancer
Cytochrome
P450
External
link
PDF
document
Excel
document
Word
document